Browsing by Subject Rabdomiossarcoma Alveolar

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
2018Fusion status in patients with lymph node-positive (N1) alveolar rhabdomyosarcoma is a powerful predictor of prognosis: Experience of the European Paediatric Soft Tissue Sarcoma Study Group (EpSSG)Gallego, Soledad; Zanetti, Ilaria; Orbach, Daniel; Ranchère, Dominique; Shipley, Janet; Zin, Angelica; Bergeron, Christophe; Salvo, Gian Luca de; Chisholm, Julia; Ferrari, Andrea; Jenney, Meriel; Mandeville, Henry; Rogers, Timothy; Merks, Johannes Hans; Mudry, Peter; Glosli, Heidi; Milano, Giuseppe Maria; Ferman, Sima Esther; Bisogno, Gianni
2019Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trialBisogno, Gianni; Salvo, Gian Luca de; Bergeron, Christophe; Melcón, Soledad Gallego; Merks, Johannes Hans; Kelsey, Anna; Martelli, Helene; Colin, Véronique Minard; Orbach, Daniel; Glosli, Heidi; Chisholm, Julia; Casanova, Michela; Zanetti, Ilaria; Devalck, Christine; Arush, Myriam Ben; Mudry, Peter; Jenney, Meriel; Ferman, Sima Esther; Ferrari, Andrea
Showing results 1 to 2 of 2